معرفی
Emily McDonald, MD, M.Sc., is an Associate Professor at the Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) within the Infectious Diseases and Immunity in Global Health Program. Her work bridges clinical practice and research, focusing on medication safety, deprescribing, and infectious disease management.
- Academic Affiliation: McGill University (Department of Medicine)
- Research Institute: RI-MUHC, Infectious Diseases and Immunity in Global Health Program
- Clinical Affiliation: Division of Internal Medicine, MUHC
Research Interests: Dr. McDonald’s research prioritizes optimizing medication use in older adults, particularly deprescribing practices to reduce polypharmacy. She investigates interventions to improve hospital resource utilization, diagnostic accuracy in infections (e.g., Pneumocystis jirovecii pneumonia), and antimicrobial stewardship in critical care. Her work often intersects with global health, focusing on HIV-related infections and pandemic response strategies (e.g., CanTreatCOVID).
Publication Trends: Her recent articles (2024–2025) emphasize
- Antibiotic duration in bloodstream infections
- Deprescribing tools (e.g., MedSafer)
- Management of opportunistic infections in immunocompromised patients
- Diagnostic innovations in HIV and endocarditis
- Public health implications of pharmaceutical overuse
- Machine learning applications in infection response prediction
Grants & Collaborations: Funded by CIHR, CABHI, Canadian Frailty Network, and MI-4. Collaborates with international networks like the Canadian Critical Care Trials Group and WikiGuidelines Group.